A convenient method for determining cyclic peptide conformation from 1D 1H-NMR information.
暂无分享,去创建一个
[1] T. Gadek,et al. Structural studies of potent constrained RGD peptides , 1992 .
[2] H. Kessler,et al. Peptide flexibility and calculations of an ensemble of molecules , 1994 .
[3] V. Bystrov. Spin—spin coupling and the conformational states of peptide systems , 1976 .
[4] L. Gierasch,et al. Design of biologically active, conformationally constrained GnRH antagonists , 1990, Proteins.
[5] Paul A. Bartlett,et al. CAVEAT: A program to facilitate the design of organic molecules , 1994, J. Comput. Aided Mol. Des..
[6] Horst Kessler,et al. Peptide conformations. 46. Conformational analysis of a superpotent cytoprotective cyclic somatostatin analog , 1988 .
[7] G. Wagner. Principles of Multidimensional NMR , 1994 .
[8] C. Humblet,et al. Design, synthesis and solution structure of a renin inhibitor Structural constraints from NOE, and homonuclear and heteronuclear coupling constants combined with distance geometry calculations , 1992, FEBS letters.
[9] M. Lipton,et al. Cyclic hexapeptides and chimeric peptides as mimics of tendamistat , 1994 .
[10] D F Mierke,et al. Coupling constants again: Experimental restraints in structure refinement , 1994, J. Comput. Aided Mol. Des..
[11] W. C. Still,et al. Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .
[12] Peter A. Kollman,et al. Can the Lennard–Jones 6‐12 function replace the 10‐12 form in molecular mechanics calculations? , 1991 .
[13] C. E. Peishoff,et al. Conformations of Arg-Gly-Asp containing heterodetic cyclic peptides: solution and crystal studies , 1992 .
[14] A. Doherty,et al. The solution structure of a cyclic endothelin antagonist, BQ‐123, based on 1H–1H and 13H–1H three bond oupling constants , 1992, FEBS letters.
[15] R. Hosur,et al. Conformation of Biological Molecules , 1982 .
[16] G. Wagner. NMR INVESTIGATIONS OF PROTEIN STRUCTURE , 1990 .
[17] S. P. Fodor,et al. Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. , 1994, Journal of medicinal chemistry.
[18] C. E. Peishoff,et al. Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides. , 1992, Journal of medicinal chemistry.
[19] Horst Kessler,et al. Conformation and Biological Activity of Cyclic Peptides , 1982 .
[20] G. Chang,et al. Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .
[21] H. Matter,et al. Structures, Dynamics, and Biological Activities of 15 Cyclic Hexapeptide Analogs of the .alpha.-Amylase Inhibitor Tendamistat (HOE 467) in Solution , 1995 .
[22] M. Bock,et al. Cyclic hexapeptide oxytocin antagonists. Potency-, selectivity-, and solubility-enhancing modifications. , 1990, Journal of medicinal chemistry.
[23] S. P. Fodor,et al. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. , 1994, Journal of medicinal chemistry.
[24] Jonathan A. Ellman,et al. SIMULTANEOUS SOLID-PHASE SYNTHESIS OF BETA -TURN MIMETICS INCORPORATING SIDE-CHAIN FUNCTIONALITY , 1994 .
[25] H. Kessler,et al. Peptide Conformation from Coupling Constants: Scalar Couplings as Restraints in MD Simulations , 1992 .
[26] H. Kessler,et al. Multidimensional NMR Spectroscopy of Peptides , 1994 .
[27] H. Kessler,et al. Coupling constants and hydrogen bonds as experimental restraints in a distance geometry refinement protocol. , 2009, International journal of peptide and protein research.
[28] W. DeGrado,et al. Template-Constrained Cyclic Peptides: Design of High-Affinity Ligands for GPIIb/IIIa , 1994 .
[29] W. Guida,et al. Probing the conformational space available to inhibitors in the thermolysin active site using Monte Carlo/energy minimization techniques , 1992 .